Drug Type iNKT cell therapy |
Synonyms- |
Target- |
Mechanism Natural killer cell replacements, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 1 | US | 01 Sep 2008 | |
Juvenile Myelomonocytic Leukemia | Phase 1 | US | 01 Sep 2008 | |
Myelodysplastic Syndromes | Phase 1 | US | 01 Sep 2008 | |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | US | 01 Sep 2008 |